It can happen that a baby is affected by a certain condition without showing symptoms.
Discovering any genetic anomalies in advance represents an important prevention opportunity because it allows for the timely application of the most appropriate therapeutic paths, such as the use of drugs, changes in lifestyle or diet.
In addition, genetic analysis is valuable in determining the presence of alterations that cannot be identified with other types of exams, allowing for better health planning.
For this reason, at Eurofins Genome, we offer different genetic tests to identify potential genetic conditions early and to facilitate the timely application of treatments.
FamilyProject does everything for the serenity of your family.
OUR POSTNATAL TESTS
- Babynext®
- GExome®
Babynext® is a non-invasive postnatal screening test that is performed on the baby with a simple oral swab. The extracted DNA is then analyzed to detect any anomalies related to over 200 genetic conditions.
It’s an early analysis that helps parents and pediatricians to identify these conditions in the early stages of the baby’s life, in order to prevent the onset of symptoms and/or cure them. For all conditions identified by Babynext®, a treatment is possible. The earlier these conditions are identified, the more prompt and timely the treatment will be.
Exome preservation
In addition to reporting on the genes investigated, Babynext® provides exome sequencing, the set of DNA regions that encode the DNA that contain the “instructions” necessary for protein production, whose data will be stored for 18 years.
More and more often, some clinical symptoms cannot be found in routine diagnosis. Genetic testing can solve this problem.
Exome preservation makes genetic data immediately available for a specific exam reducing waiting times for answers and the need for further testing.
Eurofins Genoma: by your children’s side, from birth to adulthood.
- The exome will be stored according to the rules for storing digital data and these data will be accessible until the child reaches adulthood and then transferred to the adult.
- If the child needs to undergo further exams in the future, he or she can always do so at our laboratories: having already stored his or her exome, we will start the analysis without long waits.
- The results of these further exams will then be discussed in a new genetic consultation for the result.
Who is Babynext® recommended for?
All children, from birth to 3 years even without apparent symptoms.
Exome preservation can also be extended to older brothers and sisters.
How is it performed?
The Babynext® test is performed with a simple mouth swab. You can request it from your trusted doctor or book it at one of our centers.
Genetic counseling pre- and post-test is included with Babynext®.
Conditions detected by Babynext®
Babynext® performs early screening for numerous genetic conditions and identifies them in the early stages of life, allowing parents and pediatricians to take prompt action in terms of clinical checks, treatment, and lifestyle modifications.
| Clinical area | Some of the conditions/pathologies detected by the test |
|---|---|
| Hematology |
|
| Endocrinology |
|
| Gastroenterology |
|
| Immunology |
|
| Metabolism |
|
| Nephrology |
|
| Oncology |
|
| Otolaryngology |
|
| Syndromic |
|
| Clinical area |
|---|
Hematology Some of the conditions/pathologies detected by the test:
|
Endocrinology Some of the conditions/pathologies detected by the test:
|
Gastroenterology Some of the conditions/pathologies detected by the test:
|
Immunology Some of the conditions/pathologies detected by the test:
|
Metabolism Some of the conditions/pathologies detected by the test:
|
Nefrology Some of the conditions/pathologies detected by the test:
|
Oncology Some of the conditions/pathologies detected by the test:
|
Otolaryngology Some of the conditions/pathologies detected by the test:
|
Syndromic Some of the conditions/pathologies detected by the test:
|
Why choose Babynext®?
Early Diagnosis
Babynext® allows for the early identification of diseases, even before symptoms manifest.
Targeted Therapy
Babynext® allows the doctor to identify and develop a personalized therapeutic plan.
Cutting-Edge Technology
Babynext® combines screening over 200 genes, connected to 280 conditions, with whole exome sequencing.
Results Preserved Over Time
The exome data is stored and can be consulted until the child reaches adulthood.
Your essential resource for better prevention.
Functional
For all conditions identified by Babynext® there is a treatment, which may involve the use of drugs, supplements, or lifestyle changes based on the doctor’s recommendation.
Advanced
Uses innovative and sophisticated techniques.
Useful
The preservation of the exome allows for the data to be already available for future exams, greatly reducing wait times for answers.
Fast
Results are ready in 45 working days.
GExome® is an innovative genetic test that analyzes all 20,000 human genes, always identifying the genetic alteration that caused the disease.
Genetic disorders are characterized by non-specific symptoms that make diagnosis difficult, causing sometimes a state of discomfort and frustration even within the family.
Most genetic tests focus on a single gene or a small subset, and often the anomaly is not detected. With GExome®, your doubts will finally find an answer.
How is it done?
GExome® is performed with a simple blood sample from the child.
What does the blood contain?
GExome® involves the analysis of the entire exome (the region that contains the “instructions” necessary for protein production) to detect the presence of genetic alterations responsible for Mendelian diseases, i.e. due to a single gene.
GExome® is a powerful clinical investigation tool.
Many genetic tests limit the investigation to the gene of interest. Gexome®, on the other hand, provides an advanced technological solution and investigates more than 20,000 genes simultaneously with a single sample: it is essential in the diagnosis of a pathology because it expands the clinical picture, no longer limited to observing the patient’s symptoms.
It is a high-tech test.
GExome® can detect:
Anomalies also associated with defects in a single gene (Mendelian pathologies).
Uncertain alterations associated with a pathology.
Anomalies not inherited from parents and anomalies inherited by both parents.
GExome® offers 3 diagnostic options
Clinical
Allows for the analysis of over 4,800 genes, i.e. all genes known so far to be associated with disease.
Trio
Allows for the analysis of all 20,000 human genes. The test is performed on the child and his/her biological parents.
Proband
Allows for the analysis of all 20,000 human genes. The test is performed only on the child.
We recommend GExome® in case of:
Undefined genetic disorder with multiple diagnoses.
Genetic disorder caused by various anomalies.
Suspected genetic disorder for which a specific genetic test is not available.
Previously performed genetic tests with unsatisfactory results.
We recommend GExome® for those with:
Bone and connective tissue diseases
Undiagnosed metabolic diseases
Short stature
Immunodeficiency
Ataxia
Neuropathy
Deafness
Intellectual disability/developmental delay
Cardiomyopathy
Epilepsy
Muscular dystrophy